The Eversense PASS™ Program offers savings on THE ONLY long-term CGM System with 6 months of real-time glucose readings.
The EVERSENSE PASSTM program offers savings on THE ONLY long-term CGM System with 6 months of real-time glucose readings.
$99for 6 months
Eligible individuals can experience EVERSENSE E3 CGM for only $99,now and in the future.†
That includes the patient’s initial and ongoing sensor and sensor/transmitter combinations –
which is equivalent to an average monthly cost of $16.50!
Please visit www.ascensiadiabetes.com/eversense for limitations, restrictions, references and copyright information.
† Offer does not apply to the insertion and removal procedures. The Eversense PASS Program has limitations on eligibility.
See website (bit.ly/EversensePass) for more details. Ascensia Diabetes Care reserves the right to change or terminate this program at any time without notice. The program benefit is capped per transaction. There may be instances in which out-of-pocket costs exceed what is detailed in the offer.
The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For safety information, see https://www.ascensiadiabetes.com/eversense/safety-info/
Eversense, Eversense E3 Continuous Glucose Monitoring and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia and the Ascensia Diabetes Care logo are trade marks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. Android is a trademark of Google LLC. Apple Watch is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
See below for terms and conditions. Certain restructions apply. Please complete the appropriate sections(s) of the form and check all boxes to confirm your agreement with the terms and conditions, patient authorization and patient attestations.